Panacea Index Logo

Command Palette

Search for a command to run...

Effect of including a dietary supplement of raisins, a food rich in polyphenols, on cognitive function in healthy older adults; a study protocol for a randomized clinical trial.

BMC geriatrics
January 1, 1970
María J Rodrigo-Gonzalo et al. (12 authors)
Clinical Trial ProtocolJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the effect of daily consumption of 50 g of raisins (a polyphenol-rich food) for 6 months on cognitive performance, cardiovascular risk factors, and inflammation markers in older adults without cognitive impairment.

Results Summary

The abstract does not provide results, as it describes a planned study rather than completed findings.

Population

Older adults without cognitive impairment, recruited from urban health centers in Salamanca and Zamora, Spain.

Effective Dosage

50 g of raisins daily

Duration

6 months

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
including 50 g of raisins in the diet daily for 6 months
increase
cognitive performance
older adults without cognitive impairment
-
evaluate the effect on the improvement
#1
including 50 g of raisins in the diet daily for 6 months
decrease
cardiovascular risk factors
older adults without cognitive impairment
-
evaluate the effect
#2
including 50 g of raisins in the diet daily for 6 months
decrease
markers of inflammation
older adults without cognitive impairment
-
evaluate the effect
#3
Abstract

BACKGROUND: Polyphenols have been shown to be effective against many chronic diseases, including neurodegenerative diseases. Specifically, the consumption of raisins, being a food rich in polyphenols, has been attributed with neuroprotective benefits. Therefore, our main objective is to evaluate the effect of including 50 g of raisins in the diet daily for 6 months, on the improvement of cognitive performance, cardiovascular risk factors and markers of inflammation in a population of older adults without cognitive impairment. METHODS: Design and intervention: This study will be a randomized controlled clinical trial of two parallel groups. Each subject included in the study will be randomly assigned to one of two study groups: control group (no supplement), intervention group (50 g of raisins daily during 6 months). STUDY POPULATION: The participants will be selected by consecutive sampling in the Primary Care consultations of urban health centers in Salamanca and Zamora (Spain), taking into account the selection criteria. STUDY VARIABLES: Two visits will be made, baseline and at 6 months. Cognitive performance will be evaluated (Mini-Mental State Examination test, Rey Auditory Verbal Learning Test, verbal fluency and montreal cognitive assessment (Moca)). It will also be analyzed the level of physical activity, quality of life, activities of daily living, energy and nutritional composition of the diet, body composition, blood pressure, heart rate, markers of inflammation and other laboratory tests of clinical relevance (glycaemia, total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides). In addition, sociodemographic data, personal and family history, medication use and alcohol and tobacco consumption will be collected. DISCUSSION: In this project, it is intended to contribute to minimize the problems derived from cognitive deterioration in older people. TRIAL REGISTRATION: ClincalTrials.gov Identifier: NCT04966455 Registration date: July 1, 2021.

Medical Subject Headings (MeSH)
HumansAgedVitisQuality of LifePolyphenolsActivities of Daily LivingCognitionCognitive DysfunctionDietary SupplementsInflammationRandomized Controlled Trials as Topic
Study Links
Quality Scores
SafetyNot Assessed
Quality85/10
Citation Metrics
Total Citations3
Citations/Year1.5
Relative Citation Ratio1.01
NIH Percentile50.6%
Research Impact Scores
APT Score0.50
Weight Score1.58
Normalized Score0.57
Related Supplements